Dermatology Practical & Conceptual
Instructions for Authors
The policies of the journal are based on the guidelines set forth by the International Committee of Medical Journal Editors (http://www.icmje.org). The journal follows the code on good publication practice set forth by the Committee on Publication Ethics (http://publicationethics.org/).
Dermatology Practical & Conceptual is published by Derm101.com. Derm101.com grants editorial freedom to the editor of the journal.
Open access policy
All research articles published in Dermatology Practical & Conceptual are freely and permanently accessible online. Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/3.0/). The authors retain the copyright for their published work.
Statements and opinions expressed in the articles published in Dermatology Practical & Conceptual are those of the author(s) and not necessarily those of the editorial board or the publisher. Although the editors and reviewers make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors or the publisher.
All manuscripts submitted to the journal will be initially reviewed by the editorial staff and will then be sent to at least two external referees. The author may suggest reviewers for the manuscript. Reviewers will pay particular attention to novelty, clarity, scientific accuracy, relevance, and importance of the manuscript as well as to the quality of illustrations. Dermatology Practical & Conceptual conducts anonymous and blinded peer reviews. First decisions upon acceptance of manuscripts will by made by the editor-in-chief based on the recommendation of the reviewers. First decisions usually will be made within 3-5 weeks but longer delays may occur. Four decisions are possible: (1) accept, (2) minor revisions, (3) major revisions, and (4) reject. If there is major disagreement between the two reviewers, a third reviewer is asked to assess the manuscript under consideration as well as the reviews of the other two referees. It is the policy of the journal to offer fast and fair reviews.
Conflict of interest
According to the International Committee of Medical Journal Editors (http://www.icmje.org) conflict of interest exists when “an author (or the author’s institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from being negligible to having great potential for influencing judgment. Not all relationships represent true conflict of interest. On the other hand, the potential for conflict of interest can exist regardless of whether an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, and paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion.” Dermatology Practical & Conceptual requires all authors to disclose any conflicts of interest including employment, royalties, consulting relationships, stock or other equity ownership, stock options, patent licensing arrangements, payments for conducting or publicizing a product or study.
The Journal’s authorship criteria are adapted from those of the International Committee of Medical Journal Editors (http://www.icmje.org) and are delineated on the Authorship Statement, which must be signed by each author. An “author” is generally considered to be someone who has made substantive intellectual contributions to a published study. Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Authors should meet conditions 1, 2, and 3. All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section.
It is the author’s responsibility to ensure that a patient’s anonymity be carefully protected unless written consent is obtained and submitted with the manuscript.
Institutional Review Board and Study Registration
It is the author’s responsibility to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Studies involving live human or animal subjects must have been approved by the authors’ Institutional Review Board or its equivalent. All clinical investigations must have been conducted according to the principles of the Declaration of Helsinki. Clinical trials must have been prospectively registered in a registry that meets ICMJE criteria (available at http://www.icmje.org). The registry at http://www.clinicaltrials.gov meets such requirements.
Submission of manuscripts
All manuscripts must be submitted electronically by email to firstname.lastname@example.org. An acknowlegdgement of receipt will be sent by email to the corresponding author within 48 hours.
Manuscripts should be submitted in plain English. We accept Word or RTF files. Manuscripts should be double-spaced and page-numbered starting with the title page. The title page should contain (a) the complete manuscript title; (b) authors’ full names, highest academic degrees, and affiliations; (c) name and address of correspondening author, including fax number, telephone number, and e-mail address; (d) sources of support that require acknowledgment. An authorship statement and conflict of interest statement must be submitted with each manuscript. A submitted manuscript is received with the understanding that it is an original contribution not previously published (except as an abstract or preliminary report) and that it is not under consideration for publication elsewhere.
Research Articles: In-depth observational or experimental research papers. The word count should not exceed 3000 words excluding the abstract, references, figures, and tables. All research articles should have a structured abstract not exceeding 250 words and comprising the five headings: Background, Objectives, Patients/Methods, Results, and Conclusions. Five key words need to be provided at the end of the abstract.
Reviews: Dermatology Practical & Conceptual welcomes narrative-historical and systematic reviews including meta-analyses. All systematic reviews and meta-analyses should have a structured abstract not exceeding 250 words and comprising the five headings: Background, Objectives, Patients/Methods, Results, and Conclusions. Authors are free to select more attractive headings for these paragraphs for narrative-historical reviews. The word count of reviews should not exceed 3000 words excluding the abstract, references, figures, and tables. Five key words need to be provided at the end of the abstract.
Editorials/Commentaries: This category includes commentaries that accompany papers or brief provocative, opinionated communications on a controversial subject. Most commentaries are commissioned, but unsolicited commentaries are also welcome. Unsolicited commentaries will be peer reviewed. The word count should not exceed 2000 words excluding the references, figures, and tables.
Letters: Letters, written in response to previous content published in Dermatology Practical & Conceptual. The word count of letters should not exceed 700 words excluding references, figures, and tables.
Practical, conceptual, or educational notes: Short notes on new information not readily available in textbooks for the continuing medical education of dermatologists, dermatopathologists, and general practitioners. Most notes are commissioned, but unsolicited notes are also welcome. Unsolicited notes will be peer reviewed. The word count should not exceed 700 words excluding references, figures, and tables.
Observations (case reports): Short descriptions of one or two exceptional patients with a rare or unknown disease, an unsual or unexpected presentation of a common disease, with findings that shed new light on the mechanisms of a known disease, or reports of new drug reactions. All case reports should have 3 parts, (1) an abstract not exceeding 250 words, (2) the case presentation, and (3) conclusions. The word count of typical case report should not exceed 1500 words excluding references, figures, and tables.
Quiz Cases: Quiz cases consist of clinical, dermatoscopic, or histopathologic images along with a short description of any relevant history. The discussion of the case is limited to a total of 1000 words excluding references, tables and legends. The submitted title should be descriptive and not indicate the diagnosis.
Book reviews: Books and monographs will be reviewed depending on their interest and value to our readers. Most book reviews are commissioned, but unsolicited reviews are also welcome. Unsolicited book reviews will be reviewed by members of editorial board and may be sent to external reviewers. The word count should not exceed 1000 words excluding references.
The author(s) are responsible for the accuracy of the references. References must be cited consecutively in the text and be numbered in the order in which they are discussed. Reference numbers appear in brackets after the period of a sentence. A list of references should be provided at the end of each article. If there are more than three authors, references should contain the names of the first three authors and be followed by et al. For abbreviations of journal names, refer to List of Journals Indexed in Index Medicus. This can be accessed at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:
1. McKee PH, Fletcher CDM, Rasbridge SA. The enigmatic eccrine epithelioma. Am J Dermatopathol 1990;12:552-61.
2. Calonje E, Wilson-Jones E. Vascular tumors. In: Elder D, ed. Lever’s Histopathology of the Skin. 8th ed. Philadelphia: Lippincott, 1997: 889-932.
3. Elder D, Elenitsas R. Lever’s Histopathology of the Skin. Philadelphia: Lippincott, 1997.
4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention; 1994.
5. Friedman SA. Preeclampsia: A review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.
Figures must be cited consecutively in the text and numbered in the order in which they are discussed.
Legends should be brief and specific, and they should appear after the references. Use of scale markers in the image is suggested for electron micrographs, and the type of stain used should be indicated. Photographs and micrographs should be submitted as TIFF or as a maximum quality JPG files, RGB or grayscale color mode, with a resolution 300 dpi. Line art (an image composed of lines and text, which does not contain tonal or shaded areas) should be scanned, if possible, in bitmap mode, 900-1200 dpi, and saved in TIFF format. If the line art file is only available in RGB or grayscale mode, supply at 500-900 dpi and save as maximum quality JPG. Combinations of photographs and line art (an image containing halftone plus text or line art elements) should be submitted in RGB or grayscale color mode, at 500-900 dpi, saved as maximum quality JPG. Do not imbed figures within the body of the manuscript.
Tables should be cited consecutively in the text and numbered in that order. Each table should be keyed on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not imbed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Abbreviations and style
Abbreviations must be defined at first mention in text and in each table and figure. If a brand name is cited, manufacturer and address (city and state/country) should be supplied. For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. The full term for which an abbreviation stands should precede its first use unless it is a standard unit of measure. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate the name. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in USA; city and country outside USA) of the manufacturer of any drug, supply, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius to express temperatures, and use SI units rather than conventional units. Consult the latest edition the Manual of Style by the American Medical Association for current usage.
Corresponding authors will receive page proofs via e-mail to check the copyedited article before publication. It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to make the article conform to Journal style should be allowed to stand if they do not alter the authors’ meaning. Proofs must be checked carefully and returned as requested in the cover letter accompanying the page proofs.
Manuscript submission checklist
Please include the following with your submission by mail:
- Cover letter
- The complete manuscript (in electronic format) as Word or RTF file
- Text and references double-spaced in AMA style
- One set of clearly labeled figures
- Corresponding author designated
- Email address of corresponding author
- Acknowledgments listed for grants and technical support
- Authorship statement and conflict of interest statement